Physician profile
Alison Lanman Tinker
NPI 1487111332
$459.02
in general payments reported to CMS, 2019-2025
12 companies · $91.13 in 2025
The $91.13 reported for 2025 was more than what a typical Advanced Practice Midwife provider received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.39 · 2022: $134 · 2023: $134 · 2024: $13.57 · 2025: $91.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $137.62 | 2021-2025 | |
| Organon LLC | $66.52 | 2021-2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $62.15 | 2022-2023 | |
| Hologic Sales and Service, LLC | $46.94 | 2025 | Thinprep 2000 Processor, Aptima, Novasure |
| Exeltis, USA INC. | $23.30 | 2021 | |
| Cleerly, INC. | $19.79 | 2025 | Cleerly Labs |
| C. R. Bard, INC. & Subsidiaries | $18.84 | 2023 | Bd Onclarity |
| Daiichi Sankyo INC. | $18.63 | 2022 | |
| Ascend Therapeutics US, LLC | $17.83 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.77 | 2022 | |
| Shield Therapeutics INC | $14.91 | 2023 | |
| Coopersurgical, INC. | $14.72 | 2023 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Tinker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.